Search

everythinglearnresearchcommunity

for

Search:↓

Balding might help identify men at higher risk for severe COVID-19, but more research is needed.

COVID-19 increased hair loss cases, but vaccination did not.

COVID-19-related hair loss may have unique features compared to hair loss from other causes.

Nirmatrelvir/Ritonavir treatment may lead to a weaker immune response to COVID-19, but doesn't affect the chance of rebound.

COVID-19 infection is highly related to increased hair loss, especially in women.

COVID-19 may cause hair loss due to the virus's effects and stress from the pandemic.

Hair loss is a symptom of long COVID and can be treated with a protein-rich diet.

Some people lose a lot of hair after having COVID-19.

COVID-19 protective measures led to skin irritation, hair loss, and brittle nails; using skin-friendly products and a healthy diet is recommended.

Many COVID-19 patients still have symptoms like fatigue and loss of taste or smell a month after diagnosis.

COVID-19 may cause a temporary hair loss condition called telogen effluvium in some patients after recovery.

COVID-19 infection may trigger alopecia areata in some patients.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

Most hospitalized COVID-19 patients had long-term symptoms like fatigue and hair loss, with women and those sicker during hospitalization at higher risk.

Sex hormones may affect COVID-19 severity, with men often faring worse, and targeting related pathways could offer treatment options.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Certain genetic differences may affect how likely someone is to get COVID-19 and how severe it might be.

A man experienced hair loss after getting COVID-19, which improved with treatment and might have been triggered by stress related to the illness.

Zinc acetate hydrate may help reduce fatigue and hair loss in post-COVID-19 patients.

Skin problems in COVID-19 patients are rare and may be due to the body's complex immune response or blood clotting issues.

Blocking the virus's entry into cells by targeting certain pathways could lead to early COVID-19 treatments.

The conclusion is that individual differences in COVID-19 severity are influenced by factors like age, sex, race, and genetics, which are important for personalized medicine.

Children generally have milder SARS symptoms than adults, with good outcomes and no deaths reported, but long-term effects are unclear.

Long COVID patients may have hormonal imbalances linked to their symptoms.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

Testosterone may have a dual role in COVID-19, potentially worsening outcomes in men, and testosterone therapy could help some patients, but more research is needed.

The pandemic changed how often certain skin conditions were diagnosed.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

A COVID-19 patient with severe hair loss did not improve with hair loss medication after stopping and restarting it due to the infection.

Androgen deprivation therapy might be better for preventing COVID-19 than treating it.